Genome Enhancer is a fully automated pipeline for patient’s multi-omics data analysis. It generates a comprehensive report about the personalized drug targets identified for a certain patient, or a group of patients, and the drugs that may be effective in this case. Genome Enhancer is using TRANSFAC®, TRANSPATH® and HumanPSD™ databases for the performed analysis. Learn more about Genome Enhancer.
The geneXplain platform is designed to ease the life of the bioinformatics expert who is in charge to evaluate experimental high-throughput data, but also effectively supports the experimental researcher to interpret his/her valuable data with an intuitive user interface. You are cordially invited to learn more about the geneXplain platform.
The gold standard in the field of transcriptional regulation. This database comprises a unique collection of information about transcription factors (TFs), their genomic binding sites and binding site models (positional weight matrices), suitable for search for new TF binding sites. Learn more about the TRANSFAC database.
In addition to the TRANSPATH database (see above), we make available the world’s largest collection of interactions and pathways, the GeneWays database, through our geneXplain platform.
The Human Proteome Survey Database (HumanPSD) is a rich compendium of human, mouse and rat proteins, their disease associations, biomarker properties and drug associations.
The most comprehensive information repository on enzymes and enzyme ligand data. BRENDA is an indispensable resource when working with metabolic networks.
Based on the world’s largest data collections pertaining to the biological activities of chemical compounds and their structures, PASS and PharmaExpert enable users to identify potential lead structures out of millions of chemical substances, thereby efficiently shortening development times for specific drugs or molecular probes for research purposes.
PharmaExpert analyzes the relationships between biological activities, drug-drug interactions and multiple targeting of chemical compounds and selects compounds that have a pre-defined biological activity. It helps answer a question like “How to select the most promising compounds among those known to interact with the selected protein?
Particularly valuable for experts is the program GUSAR, which enables construction of highly specific models based on own data sets.
Find history in our archive.
April 2, 2020
GeneXplain will be holding a free webinar “COVID-19 – online discovery of prospective drug targets and treatments with Genome Enhancer” on 7th and 14th of April. Register here for a convenient time for your time zone.
February 25, 2020
Join us for the Molecular Med TRI-CON 2020 in San Francisco on 1-4 March. We will be glad to meet you at our booth #524.
January 22, 2020
The video record of the passed webinar on omics data analysis and modeling organized by Optogenerapy EU project and geneXplain GmbH is available on our YouTube channel.
January 14, 2020
We are pleased to invite you to a free webinar “Omics data analysis and modelling using Genome Enhancer and its application to Optogenerapy project” organized jointly by geneXplain GmbH and Optogenerapy project EU, which will be held on January 21st, 2020 at 3 PM CET. Register here to join.